www.dermatologiepropraxi.cz 104 DERMATOLOGIE PRO PRAXI / Dermatol. praxi. 2024;18(2):97-104 / PŘEHLEDOVÉ ČLÁNKY Farmakologická léčba hyperpigmentace 63. Tadokoro T, Bonté F, Archambault JC, et al. Whitening efficacy of plant extracts including orchid extracts on Japanese female skin with melasma and lentigo senilis. J. Dermatol. 2010;37:522-530. doi: 10.1111/j.1346-8138.2010.00897.x. 64. Khosravan S, Alami A, Mohammadzadeh-Moghadam H, et al. The Effect of Topical Use of Petroselinum Crispum (Parsley) Versus That of Hydroquinone Cream on Reduction of Epidermal Melasma: A Randomized Clinical Trial. Holist. Nurs. Pract. 2017;31:16-20. doi: 10.1097/HNP.0000000000000186. 65. Ni Z, Mu Y, Gulati O. Treatment of melasma with Pycnogenol® Phytotherapy Res. 2002;16:567-571. doi: 10.1002/ ptr.1085.] 66. Babbush KM, Babbush RA, Khachemoune A. Treatment of melasma: A review of less commonly used antioxidants. Int. J. Dermatol. 2021;60:166-173. doi: 10.1111/ ijd.15133. 67. Yi X, Zhao G, Zhang H, et al. MITF-siRNA Formulation Is a Safe and Effective Therapy for Human Melasma. Mol. Ther. 2011;19:362-371. doi: 10.1038/mt.2010.263. 68. Lehraiki A, Abbe P, Cerezo M, et al. Inhibition of Melanogenesis by the Antidiabetic Metformin. J. Investig. Dermatol. 2014;134:2589-2597. doi: 10.1038/jid.2014.202. 69. Matsui MS, Petris MJ, Niki Y, et al. Omeprazole, a Gastric Proton Pump Inhibitor, Inhibits Melanogenesis by Blocking ATP7A Trafficking. J. Investig. Dermatol. 2015;135:834–841. doi: 10.1038/jid.2014.461. 70. Sehgal VN, Verma P, Srivastava G, et al. Melasma: Treatment strategy. J. Cosmet. Laser Ther. 2011;13:265-279. do i: 10.3109/14764172.2011.630088. 71. Arefiev KLB, Hantash BM. Advances in the Treatment of Melasma: A Review of the Recent Literature. Dermatol. Surg. 2012;38:971-984. doi: 10.1111/j.1524-4725.2012.02435.x. 72. Sarkar R, Garg V, Chugh S. Newer and upcoming therapies for melasma. Indian J. Dermatol. Venereol. Leprol. 2012;78:417-428. doi: 10.4103/0378-6323.98071. 73. Mazurek K, Pierzchała E. Comparison of efficacy of products containing azelaic acid in melasma treatment. J. Cosmet. Dermatol. 2016;15:269-282. doi: 10.1111/jocd.12217. 74. Huh SY, Shin JW, NA JI, et al. Efficacy and safety of liposome-encapsulated 4-n-butylresorcinol 0.1% cream for the treatment of melasma: A randomized controlled split-face trial. J. Dermatol. 2010;37:311-315. doi: 10.1111/j. 1346-8138.2010.00787.x. 75. Khemis A, Kaiafa A, Queille-Roussel C, et al. Evaluation of efficacy and safety of rucinol serum in patients with melasma: A randomized controlled trial. Br. J. Dermatol. 2007;156:997-1004. doi: 10.1111/j.1365-2133.2007.07814.x. 76. Sahu P, Dayal S. Most worthwhile superficial chemical peel for melasma of skin of color: Authors’ experience of glycolic, trichloroacetic acid, and lactic peel. Dermatol. Ther. 2021;34:e14693. doi: 10.1111/dth.14693. 77. Lim JTE. Frcpi Fams Treatment of Melasma Using Kojic Acid in a Gel Containing Hydroquinone and Glycolic Acid. Dermatol. Surg. 1999;25:282-284. doi: 10.1046/j. 1524-4725.1999.08236.x. 78. Khunger N, Sarkar R, Jain RK. Tretinoin Peels versus Glycolic Acid Peels in the Treatment of Melasma in Dark-Skinned Patients. Dermatol. Surg. 2004;30:756-760. doi: 10.1111/j.1524-4725.2004.30212.x. konference Dermatologie pro praxi 27. 2. 2025 ČESKÉ BUDĚJOVICE 1. ODBORNÝ GARANT prim. MUDr. Jiří Horažďovský, Ph.D. MÍSTO KONÁNÍ: Clarion Congress Hotel České Budějovice Pražská třída 2306/14, 370 04 České Budějovice
RkJQdWJsaXNoZXIy NDA4Mjc=